山东三元生物科技股份有限公司 2025 年半年度报告全文 山东三元生物科技股份有限公司 2025 年半年度报告 2025-070 2025 年 08 月 1 山东三元生物科技股份有限公司 2025 年半年度报告全文 第一节 重要提示、目录和释义 公司董事会、监事会及董事、监事、高级管理人员保证半年度报告内容 的真实、准确、完整，不存在虚假记载、误导性陈述或者重大遗漏，并承担 个别和连带的法律责任。 公司负责人聂在建、主管会计工作负责人于俊玲及会计机构负责人(会计 主管人员)李慧慧声明：保证本半年度报告中财务报告的真实、准确、完整。 所有董事均已出席了审议本次半年报的董事会会议。 本报告中如有涉及未来计划、业绩预测等方面的内容，均不构成本公司 对任何投资者及相关人士的承诺，投资者及相关人士均应对此保持足够的风 险认识，并且应当理解计划、预测与承诺之间的差异。敬请广大投资者谨慎 决策，注意投资风险。 公司在经营中可能存在的风险因素内容已在本报告"第三节 管理层讨论 与分析"之"十、公司面临的风险和应对措施"部分予以描述，敬请投资者 仔细阅读并注意风险。 公司计划不派发现金红利，不送红股，不以公积金转增股本。 2 ...

Summary of Key Points Core Viewpoint - On August 26, Sanyuan Bio conducted a block trade of 300,000 shares, with a transaction value of 9.099 million yuan, accounting for 6.84% of the total trading volume for the day, at a price of 30.33 yuan, which is a discount of 1.01% compared to the market closing price of 30.64 yuan [1][2]. Group 1 - The block trade involved 300,000 shares of Sanyuan Bio [1]. - The total transaction amount was 9.099 million yuan [1]. - The transaction price was 30.33 yuan per share, which is lower than the market closing price [1][2]. Group 2 - The block trade represented 6.84% of the total trading volume on that day [1]. - The buyer was Huatai Securities Co., Ltd., and the seller was CITIC Construction Investment Securities Co., Ltd. [2]. - The trade occurred on August 26, 2025, under the stock code 301206 [2].

Core Insights - As of August 22, a total of 162 stocks in the Shanghai and Shenzhen markets have experienced net financing inflows for five consecutive days or more [1] - The stocks with the longest consecutive net inflow days are Heimu Dan, Guangzhou Development, and Qilu Bank, each with 12 consecutive trading days of net inflows [1] - Other notable stocks with significant consecutive net inflow days include Xinyi Sheng, Hangjin Technology, Zhongyan Co., Sanyuan Biological, Sinan Navigation, Chengdi Xiangjiang, Rongke Technology, and Guoxin Securities [1]

Group 1 - The core transaction involved 400,000 shares of Sanyuan Bio, with a total transaction value of 12.112 million yuan, accounting for 5.24% of the total trading volume on that day [1][2] - The transaction price was 30.28 yuan per share, which represents a discount of 1.01% compared to the market closing price of 30.59 yuan [1][2]

中国发展网讯山东省滨州市作为黄河三角洲高效生态经济区的重要节点城市，正全力推进五大千亿级产 业集群转型升级与新兴产业培育。然而，在产业迭代与企业成长过程中，企业融资难、融资贵问题如同 横亘在企业发展道路上的一道关卡，严重制约着企业的发展壮大与转型升级。滨州市发展改革委立足本 地产业特色，以"靶向治疗"思维重构融资服务体系，通过打通股权融资"主动脉"、畅通小微融资"毛细 血管"、搭建信用融资"智慧桥梁"，让金融资源精准流向实体经济最需要的地方，为产业高质量发展注 入强劲动力。 激活股权融资"引擎"，为产业升级注入资本动能 股权融资作为企业直接融资的重要方式，是推动产业转型升级的核心动力。滨州市发展改革委以政策为 引领、平台为纽带、龙头为支点，构建起多层次股权融资服务体系，让资本市场的"活水"精准滴灌实体 经济。 政策赋能，厚植创投沃土。出台《推动创业投资高质量发展三年行动方案》，将创业投资发展纳入县 (市、区)考核体系，通过任务分解、定期调度、督导通报，形成上下联动的工作格局。截至目前，累计 开展创投政策培训20余场，覆盖企业负责人、金融从业者超700人次，深入企业宣讲130余次，让政策红 利直达市场主体。6月 ...

Investment Rating - The report gives an "Accumulate" rating for the sweetener industry, marking it as a first-time rating [5]. Core Insights - The sweetener market in China is poised for significant growth, with a current per capita sugar consumption of approximately 30g/day, exceeding the recommended limit of 25g/day. This indicates a substantial potential for sugar substitutes [1][9]. - The report highlights the dual demand for health and sweetness, leading to the rise of sugar substitutes. Nearly 40% of American consumers are opting for low-calorie or zero-calorie sugars to reduce calorie intake [1][17]. - The report identifies two main investment themes: the ongoing demand for artificial sweeteners like sucralose and the potential for new natural sweeteners like allulose, driven by consumer acceptance and technological advancements [3]. Market Overview - The sweetener market is characterized by a growing trend towards reduced sugar consumption, with a projected sugar consumption of 15.9 million tons in China for the 2025/26 season, reflecting a compound annual growth rate (CAGR) of about 0.5% from 2015/16 to 2025/26 [9]. - The beverage sector represents the largest share of sugar demand, with a market penetration rate for sugar-free beverages at only 7.9% in 2023, suggesting significant room for growth [20][22]. Selection Criteria - The choice of sweeteners is influenced by economic factors, taste, and safety. Artificial sweeteners generally have a higher sweetness-to-price ratio compared to natural sweeteners, which often have lower ratios [2][28]. - Safety concerns are paramount, with natural sweeteners typically having no Acceptable Daily Intake (ADI) limits, while artificial sweeteners are subject to ADI restrictions and some face safety controversies [2][40]. Product Analysis - Sucralose is identified as the largest artificial sweetener in terms of market space, with a global sales volume of approximately 20,000 tons in 2023, reflecting a 7% year-on-year growth [46]. - Erythritol, a low-calorie sugar alcohol, has seen rapid market expansion, particularly following its use in popular beverages, leading to a significant increase in production capacity [63][65]. Future Outlook - The report emphasizes the importance of consumer education and acceptance for the successful adoption of new sweeteners like allulose, which currently faces low consumer awareness [3][42]. - Investment opportunities are highlighted in companies with strong technological capabilities and financial strength, particularly those involved in the production of sucralose and erythritol [3][3].

Group 1 - On August 15, a block trade of 300,000 shares of Sanyuan Bio was executed, with a transaction amount of 8.652 million yuan, accounting for 14.55% of the total transaction volume for the day [1][2] - The transaction price was 28.84 yuan per share, which represents a 1% discount compared to the market closing price of 29.13 yuan [1][2]

证券日报网讯三元生物（301206）8月12日在互动平台回答投资者提问时表示，公司将根据市场环境、 产品定位及品牌战略综合评估广告投放的必要性与可行性，合理选择推广渠道与方式，稳步推进品牌建 设与市场拓展。 ...

证券日报网讯三元生物（301206）8月12日在互动平台回答投资者提问时表示，截至7月31日公司在册股 东为16，756户。 ...

| 股票简称 | 股票代码 | 限售股类型 | 解禁股数 | | --- | --- | --- | --- | | 中盐化工 | 600328 | 股权激励限售流通 | 96.08万 | | 北矿科技 | 600980 | 增发A股原股东配售上市 | 1211.76万 | | 福莱特 | 601865 | 股权激励限售流通 | 92万 | | 王子新材 | 002735 | 股权激励限售流通 | 408.24万 | | 三元生物 | 301206 | 延长限售锁定期流通 | 9294.6万 | | 维海德 | 301318 | 发行前股份限售流通 | 1350万 | | 满坤科技 | 301132 | 发行前股份限售流通 | 1亿 | | 亚信安全 | 688225 | | 1.91亿 | | 德科立 | 688205 | | 4419.84万 | | 碧兴物联 | 688671 | | 98.15万 | 智通财经APP获悉，8月11日共有10家上市公司的限售股解禁，解禁总市值约103.33亿元。 今日具体限售解禁股情况如下： ...